癌基因与抑癌基因课件.pptx

1、癌生物学课程提提 纲纲肿瘤发生机理肿瘤发生机理物理因子化学因子生物因子，如病毒遗传物质改变遗传物质改变正常细胞正常细胞癌细胞癌细胞 a genetic disease characterized by uncontrolled cell growth1.1.癌基因的发现癌基因的发现Non-Transforming(Avian Leukemia Viruses,ALV)1,Induce leukemia after long latency periods2,Do not“transform”tissue culture cellsVirus and CancerTransforming(Sar

2、coma Viruses,RSV)-cell free lysates could induce sarcomas in other chickens1，Acute;2，Transform cultured cells病毒致癌病毒致癌-Nobel Prize!1966BRSV(gag,pol,env,src)R.T.(1975 Nobel)gag,pol envsrccDNARSV(td:gag,pol,env)gag,pol,envDenature and Hybridize1975,1977unhybridizedsequenceshybridizedsequencesgag,pol,en

3、vsrcgenomic RNACprobeRSV-InfectedCEF(+control)“Normal”chick DNA MouseDrosophilaHuman+1989 Nobel Prize for Bishop and VarmusThus:a proto-oncogene is the NORMAL progenitor gene of a viral oncogene1980,1st oncogene identifiedSrc（v-onc,viral oncogene）Human Bladder Tumor cell line DNAIsolate high MW DNAI

4、solate DNA fragmentsRestriction endonucleaseTransfectionNIH 3T3fibroblastsTransformationIsolate DNA(99%mouse+8-10 human genes)TransformationIdentify Human DNAActivated Proto-oncogenes from DNA transfectionDRESULT:RAS“Activation”is due to a SINGLE point mutation(gly val)at codon 12Use Alu probeIsolat

5、e Human DNARESULT:A SINGLE human gene is responsible for transforming capabilitySequencingRESULT:The gene is the HUMAN c-H-ras geneCompare sequenceto NORMAL gene1st human oncogene mutationRas G12V was identified!1982,Robert Weinberg,etc three groups2.癌基因定义癌基因定义 Definitiona gene carried by a tumor vi

6、rus(RNA or DNA),the expression of which is necessary and sufficient to induce transformation in tissue culture cells and tumors in the appropriate animal.V-onc is encoded by cellular sequences that have become inserted into the viral genome.an altered gene whose product can act in a dominant fashion

7、 to help make a cell cancerous.Typically,an oncogene is a mutant form of a normal gene(proto-oncogene)involved in the control of cell growth or division.a normal cellular form of a gene that controls cell proliferation and can be converted into a cancer-promoting gene by mutation,whose continued act

8、ivation leads to continued signal transduction,and whose aberrant expression or activity may contribute to tumorigenesis.原癌基因特点原癌基因特点1Controls cell proliferation and survival;2Can be converted into oncogene,and induce transformation3Conserved across organisms4Tissue-specificPhysiological function:ce

9、ll signaling pathways tightly controlled“Hyper”-functional3.原癌基因激活机制原癌基因激活机制Transduction via retrovirusesLTRLTRViral RNAPackagingOf retrovirusgag pol envProto-oncogene is“captured”or“usurped”from host cell genomeRetrovirus without oncogeneLTRLTRgag pol env SrcRetrovirus with oncogeneRetroviral promo

10、ter/enhancer insertion Chronic Myelogenous Leukemia(CML)：chromosome 9q34(c-abl)chromosom22q11.2(bcr)，proto-oncogene c-abl is activatedChromosomal translocationq349535322q11.2ablder 9Phabl9q3422q11.222q11.29q34Der(22)DNA RNA Proteinbcrbcrbcr/abl Fusion protein Gain of multiple copies of defined chrom

11、osomal regions (1)Homogeneously staining region(HSR)(2)Double minute chromosomes (DM)Tumor OncogeneAmplificationSmall cell lung cancer c-myc Up to 8OX N-myc Up to 50X L-myc Up to 20XNeuroblastomas N-myc Up to 250XGlioblastomas c-erbB1(EGFR)Up to 50XMammary carcinoma c-erbB2(HER2)Up to 30X c-myc Up t

12、o 50X Cyclin D1 Up to 30X AmplificationCellular Proto-oncogenes amplified in human tumorsHSRDMRas：P21 transforming protein c-H-ras-Harvey rat sarcoma virus c-K-ras-Kirsten rat sarcoma virus N-ras-NeuroblastomaPoint mutationHot mutation points:12,13,61 12 Gly-Valwt-RasGTPwt-RasGDPActive formInactive

13、formmt-RasGTPmt-RasGDPConstitutively activegrowth factors(sis)GTPase proteins(ras)guanine nucleotideExchange proteins(rho)Cytoplasmic Membrane associated Tyrosine kinases(src)growth factor receptors(erb-b)nuclear transcription factors(myc)cytoplasmic serineThreonine kinases(akt)According to location

14、 and function of proto-oncogene products4.癌基因分类癌基因分类cAMP DG IP3 Ca2+Overview:Classes of oncogenes A.Secreted Growth Factors(e.g.SIS,TGF-,etc)induce cell growth by mobilisation of energy stores,differentiation and entry into the cell cycle.B.Receptors(cell surface)different cells have different recep

15、tors,thereby a signal can produce a response in some cell type but not others Cell surface receptor with protein tyrosine kinase(PTK)activity(erbB,neu/erbB-2,ros,fms)C.Intracellular Transducers act as second messengers which alter transcription,either by allowing new genes to be expressed or by modi

16、fying levels of expression of already active genes a-Protein Tyrosine Kinase(src,yes,fps,abl,met)b-Protein-Serine/Threonine kinases(akt,mos,raf)c-Ras proteins(Ha-ras,Ki-ras,N-ras)d-Adaptors(crk)D.Nuclear Transcription Factors specific binding proteins that recognise short sequence motifs within the

17、promoters and enhancers.These factors then accelerate or retard the rate of initiation of transcripts by RNA polymerase II a-jun,fos b-myc,N-myc,myb,ski,relBasic Cellular Signaling Machinery:for example Kinase signaling and CancerReceptor Protein Tyrosine Kinase Signaling Non-receptor Protein Tyrosi

18、ne Kinase Signaling Intracellular Serine/Threonine Kinase Signaling5.癌基因功能癌基因功能ABCGTPase proteinsDNuclear transcription factorE trans-membrane(glyco)proteins possess intrinsic protein tyrosine kinase (PTK)activity dimerize(homo and heterodimers)auto-,trans-phosphorylation recruit signaling molecules

19、 at specified phosphorylated sites Aberrantly expressed in many tumorsGFGFPPPPPGFPPPPReceptor Protein Tyrosine Kinase Signaling ACollection of Receptor protein Tyrosine Kinases(RPTK/RTK)GROWTH FACTORRECEPTORTYROSINEKINASEGRB-2SOSRASRAFMAPKKMEMBRANEMAPKDimerization;autophosphorylationInteraction ofsi

20、gnaling moleculesActivation of“downstream”kinasesJAKSTATPNUCLEUSMAPKPhosphorylation of transcription factorsSTATGENE EXPRESSION,i.e.,fos,jun,mycCYTOPLASMPPPPPPPPPPPPPPPP PPPPPRPTK SIGNALING CASCADES25PTK(Proto-oncogene)Viral oncogene*(viral oncoprotein)Oncogenic alterationTumour/cancer types(only th

21、e most frequent,Mainly human types are described)EGFR/ErbB1(c-erbB)V-erbB fromAEV(p68/74abB)V-erbB:Truncated EGFR PTKC-erb:Overexpression(amplification)Extracellular domain deletionsv-ErbB:fibrosarcomasc-ErbB:mammary carcinoma,glioblastoma multiforme,Cvarian,non-small-cell lung and lther cancersErbB

22、2/HER2/NeuOverexpression(amplification)No recurrent human mutations(Val664glu in rodents)Mammary,ovarian,gastric,non-small-cell lung and colon cancerErbB3/HER3Overexpression;constitutive tyrosine phosphoylation(heterodimer with ErbB2)Mammary carcinomaErbB4/HER4Overexpression Mammary carcinoma,granul

23、asa cell tumoursIGF-1ROverexpression(expression required for in vitro transformation by many oncogenes and DNA viruses)Cervical and other carcinomas,sarcomasPDGFR-Overexpression(amplification)Glioma,glioblastoma,ovarian carcinomaPDGFR-Tel-PDGR-(t(5;12)translocation fusing Ets-like Tel with PDGFR-PTK

24、 domain)OverexpressionTel-PDGFR-:chronic myelomonocytic leukaemiaPDGFR-:gliomaCSF-1R(c-fms)V-fms fromFesV(p170gag-fms)v-fms:Truncated CSF-1R PTK with mutant C-terminal tailConstitutively activec-fms:GOF point mutationsOverexpression v-fms:jeline sarcomasc-fims:acute and chronic myelomonocytic leukae

25、mias,monocytic tumours,malignant histiocytosis,endometrial cancer,gliomaKit/SCFR(c-kit)V-kit fromFeSV(p80gag-kit)v-kit:Truncated Kit/SCFR PTK with mutant C-terminal tailConstitutively activec-kit:GOF point mutations and small deletionsOverexpressionV-kit:feline fibrosarcomasC-kit:malignant gastroint

26、estinal stromal tumours,acute myeloid leukaemias,myelodysplastic syndromes,mast-cell leukaemia/systemic mastocytosis,seminomas/dysgerminomas,small-cell lung cancer and other carcinomasReceptor Protein Tyrosine Kinases and CanceractinCIP4DNAFABDFERMkinaseKinase-likePHSH2SH3Actin-binding domainBtk mot

27、ifCdc42-bindingCIP4 homology domainDNA-binging domainFocal adhosion-binding domainIntogcyin-binding domainPIK domainPscodo PIK domainPlockstrin homology domainSrc homology-2 domainSic homology-3 domainSH2kinaseSH3DNAactinSH2kinaseSH3FERMKinase-likekinasekinaseSH3SH3SH2kinasekinaseFERMFABDkinaseCIP4S

28、H2SH3kinaseSH2SH3SH2kinaseSH2SH2kinasePHSRCABLJAKACKCSKFAKFESFRKTECSYKFGR,FYN,SRC,YES1,BLK,HCK,LCK,LYNBAL,ARGJAK1,JAK2,JAK3,TYK2ACK1,ACK2CSK,MATK/CTKFAK,FESFA,PYK2BRK,FRK,SRMSBMX,BTK,ITK,TEC,TXXSYK,ZAP70Non-receptor Protein Tyrosine Kinase Signaling BROS(c-ros)v-ros fromavianUR2 SV(p68gag-ros)v-ros:

29、Truncated Ros PTK domain.Constitutively activec-ros:OverexpressionRare truncations/point mutations?v-ros:avian fibrosarcomasC-ros:glioblastomas,astrocytomasAlkNPM-Alk(t(2;5)nucleophosmin fused to Alk PTK domain)lg-Alk(t(2;22)lg fused to Alk PTK domain)Other sporadic fusions with tropomyosin,etc.Non-

30、Hodgkin lymphomas,CD30+and CD30-anaplastic large-cell lymphomaSrc(c-src)v-src fromRSV(pp60v-src)v-src:C-teminal truncation and point mutations(increased kinase activity)c-src:C-terminal truncation(increased kinase activity)Overexpression and/or increased kinase activitypp60v-sre:avian sarcomasc-Src

31、truncation:colon cancerc-Src overexpression:mammary and pancreatic cancers.neuroblastomas,othersAbl(c-abl)V-abl fromAbelson MLV(p160gag-abl)or fromP1-FeSVv-abl:N-terminal(SH3)truncation ot AblFusions:p190Bcr-Abl,(t(9;22)m-bcr);p210bct-Abl,(t(9;22)M-bcr);p230bcr-Abl,(t(9;22)-bcr).M-,m-and -bcr:3 brea

32、kpoint cluster regions in BCR.The chimaeric mRNA usually starts with exon a2 of ABL,it never includes exon 1a or 1b.Tel-Abl(t(12;22)N-terminal(H-L-Hregion of Tel fused with Abl exon 2ap160gag-abl:murine acute leukaemiasp190Bct-Abl:50%of Ph+acute lymphocytic leukaemias,rarely chronic myelomonocytic l

33、eukaemiasp210Bcr-Abl:chronic myeloid leukaemias,30%of Ph+acute lymphocytic leukaemiasp230Bcr-Abl:some Ph+chronic neutrophilic leukaemiasTel-Abl:rare cases of acute lymphocytic leukaemiasNon-receptor Protein Tyrosine Kinases and CancerSrc StructureBasal Activty(discerned from crystal structure)Activa

34、ted KinaseSrc domains and Src activityPI-3-kinaserasmycmitosismitotic functionsstress pathwaysextracellular matrixcytoskeletal reorganizationantigensoxidative stresscytokinesG protein coupled receptorsRPTKsangiogenesisRAS superfamlyCGTPase proteins1.H-ras,chr11;K-ras,chr12;N-ras,chr12.5 exons,188-18

35、9 aa,MW 21 KD3.GTPaseRAS signaling RASPI3KPIP3Akt/PKB Rho-GEFRaf(MAPKKK)MEK(MAPKK)Erk1/2(MAPK)Mnk1,RSK,Ets,Elk-1,SAP-1Ral-GEFRal-ARal-BCdc42,RacRAS mutation and CancerCatalyticregPHT308*S473*Lipid bindingSer/thr kinase*Full activation of kinase requires phosphorylation of both T308 and S473Akt struc

36、tureIntracellular Serine/Threonine Kinase SignalingDCatalyticregPHT308S473PI3KactivationPI(3,4,5,)P3PDK1PPPDK2,PDK1,ILKCatalyticregPHT308S473PPPI(3,4,5,)P3NUCLEUSGrowth factor receptorsPI(4,5,)P2Akt activationCatalyticregPHT308S473GSK3PFK-2PDE-3BmTORIkBBadp21ForkheadGlycogensynthesisProteinsynthglyc

37、olysiscAMPtranslationExpression of Fas ligandExpressionOf antiapoptotic genesBcl-XLBcl-2Cell cycleAkt/PKB-mediated signalsPI3K and MEK pathway in cancer1.c-myc,8q24,439aa;N-myc,2p23-24,456aa;L-myc,1p32,364aa2.Nuclear transcription factorNuclear transcription factorEMycMYC regulationEvidences for Tum

38、or Suppressor Genes 1969,Ephrussi and HarrisRas oncogene-NIH3T3-transformationRas oncogene-CHO-NO transformation1.抑癌基因的发现抑癌基因的发现PEDIGREE of a family with familial retinoblastoma was published by Thaddeus P.Dryja and his collaborators.Affected members are indicated by solid circles(females)or squares

39、(males).Five children in the second generation developed the tumor.One son who was unaffected had nonetheless inherited a mutated chromosome 13:two of his daughters were affected.13q14Cloning and Identification of RB gene1986 Cloning of Rb genePut Rb gene back into Rb cells-lose transforming ability

40、 such as tumorigenicity,soft agar colony forming ability1st tumor suppressor gene identified!Terminology:Tumor suppressor genes,Anti-oncogenes,Recessive oncogenesTumor Suppressor Gene：a gene whose product can negatively control cell growth and suppress cell transformation.2.抑癌基因定义抑癌基因定义Knudsons Two-

41、hit theoryDefinition:inactivation of one allele by mutations or small deletions and loss of the second allele,usually by chromosome loss(loss of heterozygosity).-chromosome loss -mutations -small intragenic deletions -promoter methylation(epigenetics)Haploinsufficiecy Inactivation of one allele is e

42、nough to lead to tumor growth3.抑癌基因失活机制抑癌基因失活机制Epigentic deregulation The methylation states of promoter and histone affect the expression level of gene 1st hit2nd hitmutMemutmutMeMeMeMeMutationMethylationLoss MethylationLoss MethylationMutation Mutation Methylation Methylation+LOH methylation Chrom

43、osome loss MethylationCancer syndromeGenePrincipal TumorsProtein Product LocalizationMode of ActionRetinoblastomaRB1Retinoblastoma.OsteosarcomaNucleusTranscriptonal regulator/factorLi-Fraumenip53Sarcomas.breast and brain tumorsNucleusTranscripton factorFamilial adenomatous polyposisAPCAdenomatous po

44、lyps.colon cancerCytoplasmRegulates -catenin functionWilms tumorWT-1NephroblastomaNucleusTranseription factorNeuofibromatosis type 1NF-1Neurofibromas.sarcomas.GliomasCytoplasmP21 ras-GTPase activatorFamilial melanoma and pancreatic cancerp16Melanoma,pancreatic cancer.NucleusCyclin-dependent kinase i

45、nhibitorFamilial breast cancer BRCA1BRCA2Breast and ovarian cancer Breast NucleusUnknownDNA repair,chromosomal stabilityTumor Suppressor Genes Associated With a Cancer SyndromeReceptor：PTCH DCCIntermediate regulators：NF1 PTEN APC NF2Transcription factors/activators：p53 WT1 RB1 VHLCell cycle inhibito

46、rs：p16 p21 p15DNA repair：MSH2 MLH1 PMS2 ATM BRCA1 BRCA2According to localization and molecular function4.抑癌基因分类抑癌基因分类Gatekeepers vs.CaretakersPTEN,p53,RB5.抑癌基因功能抑癌基因功能1.17p13.12.11 exons,393 aa,MW 53 KD3.Transactivator(TA)Transcriptional Activation domainDNA binding domainTetramerization domainGene

47、and protein structureTP53Mutations in cancers:Loss of Heterozygosity Colorectal cancers Inhibition of transformationA p53 null mouse viable loss of one or both p53 alleles gives a tumor phenotype loss of p53 cooperates with other alterations to increase tumor incidencep53:Li-Fraumeni Syndrome-an inh

48、erited predisposition to cancer-various kinds of cancers occur:osteosarcomas,soft tissue sarcomas,etc-multiple tumors in the same individual A tumor suppressor geneClassification of p53 mutationsMutant:loss of functionWide type:loss of functionp53p53p53p53Transcriptional activationMutantp53p53p53p53

49、Binds and regulates transcriptionof other genes MDR-1,c-mycp53 functionsTranscriptional Activator:binds to cis-element Cell cycle regulatory genes p21/WAF1/Cip1,GADD45,cyclin GApoptosis genes Bax,Puma,Noxa,etcRegulators of itself Mdm2,ARFInactivation of p53Ubiquitination and degradation by Mdm2(E3 l

50、igase)p53mdm2p53E2E1p53UBUBmdm2Interaction with virus proteins:SV40 large T Ag,HPV16E6,E1BT AgDNA bindingDominant-negativeMutant p53Activation of p53:increase of stabilityInhibition of Mdm2p53Mdm2p19ArfPhosphorylation of p53 Ultraviolet light Ionizing radiation Drugs(cisplatin,adriamycin)ATMATRChk1C